Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Marta Iraola Iribarren

Novo Nordisk joins forces with OpenAI to fast-track drug research

Novo Nordisk's partnership with OpenAI will “help the company bring new and better treatment options to patients faster,” the Danish pharmaceutical company announced on Tuesday.

The collaboration will allow Novo Nordisk to apply advanced AI to analyse complex datasets, identify potential drugs, and cut the time between research and patient access.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.